Journal of Bioscience and Bioengineering - Lupine Publishers

Liquid Biopsy in the OMICS Era of Tumor Medicine by Denong Wang in Open Access Journal of Biomedical Engineering and Biosciences (OAJBEB) - Lupine Publishers

Liquid biopsy uses noninvasive blood test to assess tumor heterogeneity and evolution in real time. It looks for tumor components in the blood circulation, such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), to provide tumor- specific information. By detecting multiplex tumor biomarkers, including nucleic acids, proteins, carbohydrates, and other tumor- derived substances, liquid biopsy helps with early tumor diagnosis, tumor evolution monitoring, and prognosis prediction. With the development of high-throughput OMICS tools like carbohydrate microarray and high-speed fiber-optic array scanning technology (FAST scan), it is now practical to identify glycan markers of CTCs and cancer stem cells(CSCs), especially those that are cell-surface exposed and readily accessible for immune recognition and targeting. Potential of this class of biomarkers in tumor sub typing and targeted immunotherapy is yet to be explored

To know more about  
https://lupinepublishers.com/biomedical-sciences-journal/fulltext/liquid-biopsy-in-the-oMICS-era%20of-tumor-medicine.ID.000115.php

https://lupinepublishers.com/biomedical-sciences-journal/pdf/OAJBEB.MS.ID.000115.pdf

https://lupinepublishers.com/biomedical-sciences-journal/abstracts/liquid-biopsy-in-the-oMICS-era%20of-tumor-medicine.ID.000115.php

For More Lupine Journals Click below link:
https://lupinepublishers.com/

For More Articles on  Journal of Bioscience and Bioengineering Click below link:
https://lupinepublishers.com/biomedical-sciences-journal/